Trials / Completed
CompletedNCT04888689
Holter of Movement in Patients with Multiple Sclerosis in Controlled Environment.
Holter of Movement in Patients with Multiple Sclerosis. Acti-SEP Study: Controlled Environment.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- Laurent Servais · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
ActiSEP is a multicentric academic study. Ambulant patients with multiple sclerosis may be included on a voluntary basis. We plan to include a group of approximately 20 patients with MS. This study include a unique evaluation in the laboratory of analysis of human movement. A set of tasks will be performed by patients wearing of two magneto-inertial sensors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Actimyo° | Actimyo° is an innovative device intended to be used in a home-based environment. It is composed of two watch-like sensors, each containing a magneto-inertial sensors that record the linear acceleration, the angular velocity, the magnetic field of the movement in all directions.The two watches can be worn as wristwatch or placed near the ankle. |
| DEVICE | IMU | IMU is a portable system of miniaturized inertial sensors for objective, instrumental, ambulatory, and validated analysis of normal and pathological human gait. Each miniaturized inertial sensor (2 cm × 0.7 cm × 0.5 cm) includes a triaxial accelerometer and a triaxial gyroscope. These four inertial sensors are connected to a box by wires and are numbered 1 to 4. They must be attached - using adhesive tapes - on the participant's shoes. |
Timeline
- Start date
- 2021-02-04
- Primary completion
- 2021-09-30
- Completion
- 2021-09-30
- First posted
- 2021-05-17
- Last updated
- 2025-02-12
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT04888689. Inclusion in this directory is not an endorsement.